Rakusen's Foods

4 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• LACKS N/C2 refused lines

  Net quantity statement missing

  The packaged food appeared not to carry an accurate statement of the quantity of contents, such as net weight, measure, or count, on its label.

• LIST INGRE2 refused lines

  Ingredients not listed

  The product is made from two or more ingredients and the label appeared not to list the common or usual name of each one (or, for a juice beverage, the percentage of juice).

• NUTRIT LBL2 refused lines

  Nutrition information missing from label

  The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

• UNSAFE COL1 refused line

  Color additive unsafe under section 721

  The product appeared to be, or to contain, a color additive that is unsafe within the meaning of section 721(a) of the FD&C Act, the section that governs which color additives may be used and how.

Questions about Rakusen's Foods

Is Rakusen's Foods on an FDA import alert?

Yes. As of October 26, 2026, Rakusen's Foods is on the red list of FDA Import Alert 45-02, “Foods with illegal or undeclared colors”, for loprofin low protien crackers; FDA published the listing on March 13, 2018.

Has FDA refused shipments from Rakusen's Foods?

Yes. FDA refused 3 shipment lines from Rakusen's Foods between March 29, 2018 and June 15, 2020. The most recent, on June 15, 2020, was nutritionally complete formulations, charged as UNSAFE COL (color additive unsafe under section 721).

Why did FDA refuse Rakusen's Foods's shipments?

The most frequent charges are LACKS N/C (net quantity statement missing, 2 lines) and LIST INGRE (ingredients not listed, 2 lines).

What is Rakusen's Foods's FEI number?

Rakusen's Foods's FDA Establishment Identifier (FEI) is 1000470382.

Can shipments from Rakusen's Foods still enter the U.S.?

Shipments of loprofin low protien crackers from Rakusen's Foods can be detained without physical examination under Import Alert 45-02; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).